• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Aung Naing Lin, MD

Latest:

AHA Telemetry Guidelines Improve Telemetry Utilization in the Inpatient Setting

Using Plan-Do-Study-Act cycles, the studied intervention reduced hospital inpatient telemetry time by 51.25% while increasing American Heart Association (AHA) guideline–based usage.


Danielle Feffer, BA

Latest:

Characteristics, Utilization, and Concentration of Outpatient Care for Dual-Eligible Medicare Beneficiaries

Outpatient care for dual-eligible beneficiaries is concentrated among a small group of physicians, and these beneficiaries receive less subspecialty care despite having more chronic conditions.


Joohyun Park, PhD

Latest:

Part D Coverage Gap Reform: Trends in Drug Use and Expenditures

This study analyzed annual trends in the distribution of beneficiaries entering each benefit phase, drug utilization, and expenditures among Part D beneficiaries from 2008 to 2015.


Patrick White, MD, HMDC

Latest:

Using Electronic Health Records and Claims Data to Identify High-risk Patients Likely to Benefit From Palliative Care

Deep learning algorithms could improve palliative care by predicting mortality from electronic health records and claims data.



Celeste Campos-Castillo, PhD

Latest:

Telehealth Use in 2022 Among US Adults by Sexual Orientation

In a 2022 survey representative of US adults, sexual minority individuals reported greater rates of telehealth use, especially for mental health visits, than heterosexual individuals.


Suzzette Arnal, PhD

Latest:

Bridging the Gap Between Biomarker Testing and Treatment in Community Oncology

McKesson's Precision Care Companion initiative enhances biomarker testing and targeted therapies in community oncology, improving patient outcomes and cost efficiency.


Nicoletta Colombo, MD, PhD

Latest:

Metronomic Chemotherapy a Key Aspect of KEYNOTE-B96 Regimen: Nicoletta Colombo, MD, PhD

Nicoletta Colombo, MD, PhD, of the University of Milan-Bicocca, discussed key aspects of the KEYNOTE-B96 trial of paclitaxel with bevacizumab and pembrolizumab in ovarian cancer.


Marisa Davis, BSPH

Latest:

Disconnects Between Provider Network Directories and Patient Preferences

This study found widespread instances of disconnect in online provider directories between information needed by patients and data availability.


Nancy Ross, PharmD, BCACP, MSCS, CSP

Latest:

Future of MS Management

Key opinion leaders in MS provide closing thoughts on the future of MS treatment including digital therapeutics, new generics, and pipeline drugs on the horizon.


Timothy Grigsby, PhD

Latest:

ACA Dependent Coverage Extension and Young Adults’ Substance-Associated ED Visits

This study examines the impact of the Affordable Care Act (ACA) on substance-associated emergency department (ED) visits among young adults, revealing reduced alcohol-associated visits but unchanged opioid-associated visits.


Ashley Ellis, PharmD

Latest:

Building a Payment Model for Health Coaching in Primary Care: Lessons From Tennessee

This case study describes Tennessee’s process for convening key stakeholders to develop uniform payment guidelines to encourage increased preventive service delivery.


Frederick L. Locke, MD
Frederick L. Locke, MD

Latest:

MRD Status Guides Consolidation With Cema-Cel in ALPHA3 Trial: Fred Locke, MD

The ALPHA3 trial is exploring cemacabtagene ansegedleucel's (cema-cel) potential to enhance outcomes in patients who have relapsed/refractory large B-cell lymphoma, particularly those positive for minimal residual disease.


Kevin M. Chiang, PharmD, MBA

Latest:

Real-World Value of Direct-Acting Antivirals for Hepatitis C at Kaiser Permanente Southern California

This analysis demonstrates value and innovation of direct-acting antivirals for the treatment of chronic hepatitis C in the US Kaiser Permanente health system.


Soraida Khalaily, MD

Latest:

Promoters of Therapeutic Inertia in Managing Hypertension: A Consensus-Based Study

The authors identified consensus-based promoters of clinical inertia in managing hypertension. Policy makers should address these promoters to improve health-related outcomes in hypertension.


Lambros Chrones, MD

Latest:

Mental Health Diagnoses and Services Utilization Vary by Wage Level

Insured lower-wage employees had lower prevalence of mental health conditions but greater severity, with more hospital admissions and emergency department visits than high-wage employees.


Ajeet Gajra, MD

Latest:

Oncologists’ Perceptions and Utilization of US Therapeutic Oncology Biosimilars

Biosimilar use in clinical practice is determined by oncologists’ perceptions of and willingness to prescribe them. The authors investigated US oncologists’ perceptions and use of biosimilars.


Perry B Shieh, MD, PhD

Latest:

MD Treatment From a Managed Care Perspective

Panelists discuss how payers seek good return on investment when evaluating expensive gene therapies, creating potential friction when innovative treatments come at significant costs, requiring ongoing dialogue between manufacturers, patients, payers, and physicians to determine appropriate value and access.


Rebecca Flournoy, MPH

Latest:

Telehealth Insights From an Integrated Care System

Experiences from a large, integrated, value-based health system suggest that telehealth can be an effective care delivery approach. Public policies can improve telehealth access and care.


Randall Owen, PhD

Latest:

Reply to “Industry-Informed Perspectives on the Benefits of Rideshare-Based Medical Transportation”

The authors of “Rideshare Transportation to Health Care: Evidence From a Medicaid Implementation” respond to a letter to the editor.


Jill Soderquist, MBA

Latest:

Screening for Health Literacy, Social Determinants, and Discrimination in Health Plans

This study provides insight on the experiences of patients of a national health plan with 2 structural determinants of health—health care discrimination and health literacy—and how those interact with social determinants of health and patient demographics.


DeShawn Wilbern, MBA

Latest:

Access Denied: CMS’ Action Hurts Patients With Cancer in Rural America

CMS rules hindered the access of rural patients with cancer to medically integrated pharmacies in 2023. The authors discuss the impact on equity in health care, emphasizing the need for regulatory change.


John N. Mafi, MD, MPH

Latest:

Impact of Telemedicine Use on Outpatient-Related CO2 Emissions: Estimate From a National Cohort

Telemedicine was associated with a monthly avoidance of greenhouse gas emissions equivalent to the emissions of 61,255 to 130,076 passenger vehicles.


Chiu-Mei Yeh, MS

Latest:

Hospital Partnership and Patient Outcomes Among Postacute Patients With Stroke

This article explores the patient-sharing relationships between acute hospitals and postacute hospitals and how these relationships influence patient discharge outcomes.


Andrea Iannucci, PharmD, BCOP

Latest:

Patient Cost, Convenience Important Considerations When Reviewing Formulary Approvals in Oncology: Q&A With Andrea Iannucci, PharmD, BCOP

The ease of acquiring prior authorizations for a new formulary drug plays a part in evaluating oncology drugs that are new to the market.


Jeanne Jiang, MS

Latest:

Outcomes in Patients With IBD Stratified by Risk of Disease Progression

This study validates criteria to identify patients with inflammatory bowel disease (IBD) at risk of worsening disease who may benefit from early treatment with advanced therapies.



James Frisbie, MD

Latest:

Incidence and Cost of Potentially Avoidable Emergency Department Visits for Urolithiasis

This study characterizes the incidence and associated factors of urolithiasis-related emergency department visits that are potentially preventable with appropriate ambulatory care and calculates their cumulative costs.


Bob Kronemyer

Latest:

Frequency of Condomless Sex Among Women Using Reversible Methods of Contraception

A substudy of the Evidence for Contraceptive Options and HIV Outcomes trial, which compared 3 highly effective, reversible methods of contraception, concluded that women assigned either a copper intrauterine device or the levonorgestrel implant may have had condomless sex more frequently than women assigned to intramuscular depo-medroxyprogesterone acetate.


© 2026 MJH Life Sciences
AJMC®
All rights reserved.